Plain-English translation of NCT06223906 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a registry study — a large research database — designed to collect medical records, ultrasound imaging, and health information from people diagnosed with heart valve disease. Researchers are looking for biological markers (signs in the body that indicate disease) that could help doctors better understand and treat conditions like aortic stenosis and mitral regurgitation, which affect the heart's valves.
Heart valve disease affects millions of people, especially older adults, and can cause serious health problems. However, doctors still don't fully understand why these conditions develop or how to best treat them. This study aims to find biological clues that could lead to better prevention and treatment strategies.
You likely qualify if…
You likely don't qualify if…
As a participant, you would allow researchers to access your existing medical records and heart ultrasound images already collected during your regular care. You would likely have periodic follow-up appointments where your health status is monitored and recorded. The study involves no experimental medication or invasive procedures — it's about gathering and analyzing information you already have from your medical care.
AI-generated summary from trial data · Jun 28, 2026 · Not medical advice
China
Enrollment target
~200,000 participants
Started
January 2016
Primary completion
January 2030
Age range
18 Years – 100 Years
Last updated on clinicaltrials.gov in January 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Yuan Wang, Dr
The Key Laboratory of Remodeling-Related Cardiovascular Disease, Ministry of Education, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart,Lung and Blood Vessel Diseases
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.